Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.78 USD | -0.28% | +9.30% | -11.50% |
02:55pm | Pacira BioSciences Prices $250 Million Convertible Senior Notes Offering | MT |
08/05 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.50% | 1.39B | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+16.92% | 239B | |
+8.15% | 204B | |
-8.06% | 198B | |
+8.62% | 168B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Transcript : Pacira BioSciences, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 08